Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients — EPIPHARM  

Epilepsy Clinical Trial

Official title: Study of the Impact of Pharmaceutical Interventions on the Medication Adherence of Epileptic Patients and Their Medication Knowledge

Status Recruiting

Clinical Trial Summary

Many studies have reported a disparity in medication adherence among epileptic patients. In this population, Medication Possession Ratio (MPR) is an index of medication adherence. MPR is defined as the ratio of the number of days of treatment delivered to the number of days in the period of interest.

No-adherents patients are defined by a MPR of less than 80% , in whom an increase in seizures and the rate of hospitalization can be observed. A pharmacist-led intervention and medication information to epileptic patients could improve patient medication adherence to antiepileptic drugs, and possibly decrease the frequency of seizures, hospitalizations and the health costs generated by these hospitalizations. This intervention could also improve patient knowledge about their medications.

The aim of this study is to evaluate the effectiveness of a pharmacist-led intervention on medication adherence of epileptic patients with the MPR. Secondary objectives include the comparison of medication adherence with health insurance score, the evaluation of patients knowledges about their medications, community pharmacists' satisfaction about community hospital network, the comparison of the seizure free patient rate and the comparison of the rate of patient in whom seizure have decreased by 50%

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Epilepsy

• NCT number: NCT04876820
• Study type: Interventional
• Source: University Hospital, Lille
• Contact: Philippe DERAMBURE, MD,PhD
• Phone: 0320445962
• Email: philippe.derambure@chru-lille.fr
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2021
• Completion date: October 2023